Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · IEX Real-Time Price · USD
0.202
+0.009 (4.87%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $12.99 million as of July 2, 2024. Its market cap has decreased by -87.47% in one year.
Market Cap
12.99M
Enterprise Value
23.56M
1-Year Change
-87.47%
Ranking
Category
Stock Price
$0.20
Market Cap Chart
Since September 10, 2021, Calidi Biotherapeutics's market cap has decreased from $248.50M to $12.99M, a decrease of -94.77%. That is a compound annual growth rate of -65.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 10.30M | -80.75% |
| Dec 29, 2023 | 53.50M | -46.77% |
| Dec 30, 2022 | 100.50M | -64.36% |
| Dec 31, 2021 | 282.00M | 13.48% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 13.64M |
| Edesa Biotech | 13.54M |
| Avalo Therapeutics | 13.41M |
| NEXGEL | 13.33M |
| Flora Growth | 13.23M |
| Kiora Pharmaceuticals | 13.13M |
| Bullfrog AI | 13.11M |
| BioRestorative Therapies | 13.07M |